Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 18,212 shares at $7.78 ($142K) on 2018-11-02, disclosed to the SEC on 2018-11-06.
Open-market sale of $142k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.78 | 7,356 | $57K | 40.2% |
| 2 | $7.78 | 7,356 | $57K | 40.2% |
| 3 | $7.96 | 3,500 | $28K | 19.6% |
| Total | $7.81 avg | 18,212 | $142K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |